Mostrar el registro sencillo

dc.contributor.authorPrieto Peña, Diana 
dc.contributor.authorCastañeda, Santos
dc.contributor.authorAtienza Mateo, Belén 
dc.contributor.authorBlanco Alonso, Ricardo 
dc.contributor.authorGonzález-Gay Mantecón, Miguel Ángel 
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2022-03-29T15:15:46Z
dc.date.available2022-03-29T15:15:46Z
dc.date.issued2021
dc.identifier.issn1178-7015
dc.identifier.urihttp://hdl.handle.net/10902/24432
dc.description.abstractGiant cell arteritis (GCA) is characterized by granulomatous inflammation of large and medium-sized vessels. It is the most common vasculitis among elderly people in Europe and North America. GCA usually presents with ischemic cranial manifestations such as headache, scalp tenderness, visual manifestations, and claudication of the tongue and jaw. Thickness and tenderness of temporal arteries are the most recognizable signs of GCA on physical examination. Laboratory tests usually show raised acute phase reactants. Skin manifestations are uncommon in GCA and are rarely found as a presenting symptom of GCA. Necrosis of the scalp and tongue is the most common ischemic cutaneous manifestation of GCA. Although infrequent, when present it reflects severe affection and poor prognosis of GCA. Panniculitis-like lesions have been reported in the setting of GCA, with nodules being the most common finding. Other entities, such as generalized granuloma annulare or basal cell carcinoma have been occasionally described in GCA patients. Prompt recognition and initiation of therapy are crucial to prevent serious complications of GCA. When high suspicion of GCA exists, immediate administration of glucocorticoids is recommended. It is advisable to refer the patient to a specialist GCA team for further multidisciplinary assessment.es_ES
dc.description.sponsorshipFunding: This line of research on vasculitis was partially supported by RETICS Programs, RD08/0075 (RIER), RD12/0009/ 0013 and RD16/0012 from “Instituto de Salud Carlos III” (ISCIII) (Spain).es_ES
dc.format.extent10 p.es_ES
dc.language.isoenges_ES
dc.publisherDove Medical Presses_ES
dc.rights© 2021 Prieto-Peña et al. This work is published and licensed by Dove Medical Press Limited.es_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.sourceClin Cosmet Investig Dermatol . 2021 Mar 25;14:303-312es_ES
dc.subject.otherGiant cell arteritises_ES
dc.subject.otherCutaneous manifestationses_ES
dc.subject.otherSkines_ES
dc.subject.otherVasculitises_ES
dc.titleA Review of the Dermatological Complications of Giant Cell Arteritises_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttp://doi.org/10.2147/CCID.S284795es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.2147/CCID.S284795
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

© 2021 Prieto-Peña et al. This work is published and licensed by Dove Medical Press Limited.Excepto si se señala otra cosa, la licencia del ítem se describe como © 2021 Prieto-Peña et al. This work is published and licensed by Dove Medical Press Limited.